Otonomy Closes $38.5 Million Series B Financing

Strong investor syndicate to fund Otonomy to become leading company in the development of locally delivered therapeutics for ear disorders

San Diego, Aug. 30, 2010

Otonomy, Inc. announced today that it has closed a $38.5 million Series B financing co-led by Novo Ventures and RiverVest Venture Partners, and joined by Domain Associates and TPG Biotech. This financing is incremental to the $10 million Series A closed with Avalon Ventures in June 2010. Avalon also participated in the Series B round.

Click here to read Otonomy's news release.